|
Issues (Archived 12/19/2008)
Announcement: Public Teleconference with Dr. Steven Libutti of the National Cancer Institute to discuss the development of an improved method for diagnosing benign versus malignant thyroid lesions
This technology, which uses fine needle aspiration biopsy (FNA), makes use of gene expression profiles and/or their proteins to accurately distinguish malignant thyroid nodules from benign nodules. Additional details were published in the Federal Register on Wednesday, November 5, 2008 [73 FR 65862-65863].
Licensing and collaborative research opportunities will also be discussed.
Date and Time: Wednesday, December 17, 2008 at 2 PM (EST)
Contact for Details and Call-in Instructions: Adaku Nwachukwu; Email: madua@mail.nih.gov; Phone: 301-435-5560.
Archived Issues..
|
